Research by PwC Strategy& takes a value-led approach to identifying GenAI opportunities and assessing the potential level of disruption and change in a number of industries. The research reveals significant variation in how GenAI will impact a set of different industries across the UK and EMEA, identifies some of the most compelling areas of opportunity and explores potential barriers, in analysing the value GenAI can create.
Pharmaceuticals and life sciences, along with banking, media and technology, are among the sectors with the greatest immediate opportunities for value creation, according to the research which considers six strategic viewpoints and 20 value drivers.
While no industry or sector will be untouched by GenAI, in sectors such as retail and corporate banking and insurance – where operating costs are high – efficiency is a commonly cited benefit of GenAI.
Read more on their website.